SCHEMBL30009880

SCHEMBL30009880

O=C(O)Cc1cccc2[nH]ccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 1/20 0.54
GRIN3B O60391 1/20 0.54
GRIN1 Q05586 1/20 0.54
GRIN2A Q12879 1/20 0.54
GRIN2B Q13224 1/20 0.54
GRIN2C Q14957 1/20 0.54
GRIN3A Q8TCU5 1/20 0.54
TDP1 Q9NUW8 2/20 0.53
ALDH1A1 P00352 3/20 0.53
KDM4E B2RXH2 3/20 0.53
MEN1 O00255 2/20 0.53
MAPT P10636 2/20 0.53
KMT2A Q03164 2/20 0.53
POLB P06746 1/20 0.53
GAA P10253 1/20 0.53
THRB P10828 1/20 0.53
DNMT1 P26358 1/20 0.53
RECQL P46063 1/20 0.53
CASP6 P55212 1/20 0.53
MCL1 Q07820 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4309213 1.00 GRIN2D (0.54) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Hydrochloric Acid SCHEMBL1374957 0.98 GRIN2D (0.53) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Indole SCHEMBL28550516 0.91 TDP1 (0.57) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL8186005 0.87 GRIN2D (0.43) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL7674165 0.86 MAPT (0.64) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL29777099 0.84 GAA (0.54) ALDH1A1KDM4EMEN1MAPTKMT2A
SCHEMBL10717270 0.84 GLS (0.50) ALDH1A1KDM4EMEN1MAPTKMT2A
SCHEMBL14987599 0.84 GAA (0.54) ALDH1A1KDM4EMEN1MAPTKMT2A
SCHEMBL27644456 0.83 PARP1 (0.68) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL25139801 0.81 GLS (0.48) ALDH1A1KDM4EMEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3721711-B1 AGENT FOR CONTROLLING UNWANTED PLANTS PREMIER TECH TECH LTEE (CA) 2024-11-20 EP disclosed
EP-4440573-A1 NOVEL AZA-SUBSTITUTED PSILOCIN ANALOGS AND METHODS OF SYNTHESIZING THE SAME Mydecine Innovations Group Inc. (US) 2024-10-09 EP disclosed
WO-2023101722-A1 NOVEL AZA-SUBSTITUTED PSILOCIN ANALOGS AND METHODS OF SYNTHESIZING THE SAME MEDECINE INNOVATIONS GROUP INC. (US) 2023-06-08 WO disclosed
US-11606956-B2 4-chloroindole-3-acetic acid for controlling unwanted plants PREMIER TECH TECHNOLOGIES LTÉE (CA) 2023-03-21 US disclosed
US-11478449-B1 Compositions of matter and pharmaceutical compositions PSILERA INC. (US) 2022-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11478449-B1 Compositions of matter and pharmaceutical compositions TPH1, HTR1B, HTR2C GRIN2D 353/4885GRIN3B 129/4885GRIN1 292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.